sprite-preloader
Anzeige
Mehr »
Montag, 23.04.2018 Börsentäglich über 12.000 News von 574 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:43Fresenius Kabi scraps $4.3bn merger with US generic drugmaker Akorn
FrHelperby Therapeutics' combination antibiotic therapy is effective against WHO critical priority pathogen in phase 1 study
FrTmunity raises another $35m to advance T Cell therapies
FrShire rejects $63bn takeover proposal from Takeda
DoBenevolentAI raises $115m to advance AI-enabled drug development activities
DoFDA approves Tagrisso as first-line treatment for EGFR-mutated non-small cell lung cancer
DoSandoz, Pear to commercialize prescription digital therapeutics
DoMerck to sell global consumer health business to P&G for $4.2bn
MiRoche's Hemlibra gets FDA breakthrough status in haemophilia A without inhibitors
MiCatabasis Pharmaceuticals to reduce workforce by about 42%
MiNovartis announces $100m to advance research and develop next-generation antimalarials
MiAdvent in talks to buy Sanofi's European generics business for EUR1.9bn
DiAlliance Pharma divests 60% stake in Unigreg
DiBoehringer Ingelheim, Lilly, University of Oxford to study empagliflozin in chronic kidney disease
DiBMS' Opdivo and Yervoy combo gets FDA approval for firstline RCC
16.04.Servier to buy Shire's oncology business for $2.4bn
16.04.Kalytera scraps pre-clinical programs in bone disease
16.04.Merck's Keytruda significantly decreases risk of disease recurrence in melanoma study
16.04.AstraZeneca's Tagrisso shows sustained PFS in phase 3 lung cancer trial
13.04.Sanofi to invest €350m for new vaccine manufacturing facility in Canada
13.04.Inovio secures $56m from CEPI to advance DNA vaccines against Lassa fever and MERS
13.04.Orchard Therapeutics to buy GSK's rare disease gene therapy portfolio
12.04.Personalized tumor vaccine yields promising results in pilot trial
12.04.Mylan bags license to commercialize Fujifilm's Humira biosimilar in Europe
12.04.Alexion to acquire Wilson Therapeutics for $855m